|
| 36513858 | Clinical efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: five-year real-world results. | Eye (Lond) | 2023 |
| 37632337 | Stroke risk management in carotid atherosclerotic disease: A Clinical Consensus Statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases. | Cardiovasc Res | 2023 |
| 33935487 | Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years' Real-World Clinical Outcomes. | Clin Ophthalmol | 2021 |
| 33866023 | Evolving Treatment Patterns and Outcomes of Neovascular Age-Related Macular Degeneration Over a Decade. | Ophthalmol Retina | 2021 |
| 34670353 | Patient perceptions on telemedicine eye clinics during COVID-19 pandemic. | Int J Clin Pract | 2021 |
| 32273680 | Combination Therapy for Macular Oedema in Retinal Vein Occlusions: 3-Year Results from a Real-World Clinical Practice. | Clin Ophthalmol | 2020 |
| 33061282 | Ultra-Widefield Fluorescein Angiographic Patterns, Retinal Microvascular Anomalies and Retinal Ischemic Index in Branch Retinal Vein Occlusions with Established Retinal Neovascularization. | Clin Ophthalmol | 2020 |
| 30269098 | United Kingdom Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group: report 4, real-world data on the impact of deprivation on the presentation of diabetic eye disease at hospital services. | Br J Ophthalmol | 2019 |
| 31849444 | Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8). | Clin Ophthalmol | 2019 |
| 29099501 | Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result. | Eye (Lond) | 2018 |
| 29934633 | Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection. | Eye (Lond) | 2018 |
| 28106887 | Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom. | Eye (Lond) | 2017 |
| 26795414 | Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes. | Eye (Lond) | 2016 |
| 27170504 | Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes. | Eye (Lond) | 2016 |
| 27167587 | Intravitreal anti-vascular endothelial growth factor in early pregnancy and the complex management of advance diabetic retinopathy and maculopathy during pregnancy. | Acta Ophthalmol | 2016 |
| 27256303 | Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review. | Eye (Lond) | 2016 |
| 26962382 | Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration. | Open Ophthalmol J | 2015 |
| 26445525 | One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK. | Clin Ophthalmol | 2015 |
| 24642665 | Atrial fibrillation and retinal vein or artery occlusion: looking beyond the eye. | Br J Ophthalmol | 2014 |
| 24812486 | Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema. | Clin Ophthalmol | 2014 |
| 21235693 | Renin-angiotensin blockade in diabetic retinopathy. | Int J Clin Pract | 2011 |
| 21325396 | Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema--a mechanism for regulating angiogenesis? | Br J Ophthalmol | 2011 |
| 21314873 | Peri-operative management of ophthalmic patients taking antithrombotic therapy. | Int J Clin Pract | 2011 |
| 19689249 | Diabetic retinopathy in pregnancy. | Curr Diabetes Rev | 2009 |
| 15965157 | The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. | Br J Ophthalmol | 2005 |
| 14762437 | Postoperative infection and subtenon anaesthesia. | Eye (Lond) | 2004 |
| 15548809 | Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. | Br J Ophthalmol | 2004 |
| 14707976 | A non-idiopathic case of polypoidal choroidal vasculopathy. | Eye (Lond) | 2004 |
| 11834138 | Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. | Clin Sci (Lond) | 2002 |
| 12386093 | Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma. | Br J Ophthalmol | 2002 |
| 11466264 | Further pathophysiological insights into age related macular degeneration. | Br J Ophthalmol | 2001 |
| 11351979 | A postoperative complication far worse than endophthalmitis: the coexistence of orbital cellulitis. | Br J Ophthalmol | 2001 |
| 11297487 | Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. | Ophthalmology | 2001 |
| 11027016 | Worsening of an existing hemispheric retinal vein occlusion following further hypotony procedure. | Eye (Lond) | 2000 |
| 10892852 | Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. | Invest Ophthalmol Vis Sci | 2000 |
| 11584859 | Extensive globe rupture from blunt trauma: a case with a hope. | Eye (Lond) | 2000 |
| 11116687 | Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations. | Eye (Lond) | 2000 |
| 10624449 | Reversible anterior ischaemic optic neuropathy in accelerated hypertension. | Eye (Lond) | 1999 |
| 10396378 | Sorsby's fundus dystrophy: a case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography. | Eye (Lond) | 1999 |
| 10636679 | Central serous retinopathy complicated by massive bilateral subretinal haemorrhage. | Br J Ophthalmol | 1999 |
| 9683948 | Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. | Eye (Lond) | 1998 |
| 9826034 | Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy? | Acta Ophthalmol Scand | 1998 |
| 9416937 | Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. | Am J Cardiol | 1997 |
| 9249235 | Fundal changes in malignant hypertension. | J Hum Hypertens | 1997 |
| 8595318 | Why do old men have big ears? The Chinese believe that thick ears signify greater wealth. | BMJ | 1996 |
| 8759084 | Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. | Circulation | 1996 |
| 8903631 | Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. | J Hypertens | 1995 |